Isolation of hypoxia-inducible factor 1 (HIF-1) inhibitors from frankincense using a molecularly imprinted polymer

Investigational New Drugs

Volumn 29, Issue 5, 2011, Pages 1081-1089

  Lakka, Achillia ^a   Mylonis, Ilias ^a,b   Bonanou, Sophia ^a   Simos, George ^a,b   Tsakalof, Andreas ^a,b  

^a UNIVERSITY OF THESSALY   (Greece)

^b INSTITUTE OF HUMAN PERFORMANCE AND REHABILITATION   (Greece)

Author keywords

Acetyl 11 keto boswellic acid; Cancer; Drug discovery; Frankincense; Hypoxia Inducible Factor 1; Molecular imprinting

Indexed keywords

11 OXO BETA BOSWELLIC ACID; ACETYL 11 OXO BETA BOSWELLIC ACID; CHEMICAL COMPOUND; FRANKINCENSE; HYPOXIA INDUCIBLE FACTOR 1; HYPOXIA INDUCIBLE FACTOR 1ALPHA; MOLECULARLY IMPRINTED POLYMER; QUERCETIN; RESIN; UNCLASSIFIED DRUG; ANTINEOPLASTIC AGENT; BOSWELLIC ACID; POLYMER; TRITERPENE;

ARTICLE; BINDING AFFINITY; BOSWELLIA; CHEMICAL COMPOSITION; CONTROLLED STUDY; DRUG IDENTIFICATION; DRUG ISOLATION; DRUG SCREENING; MOLECULAR IMPRINTING; MOLECULAR RECOGNITION; PRIORITY JOURNAL; PROTEIN SYNTHESIS INHIBITION; SIGNAL TRANSDUCTION; SOLID PHASE EXTRACTION; TRANSCRIPTION REGULATION; CHEMISTRY; DRUG ANTAGONISM; DRUG EFFECT; GENETIC TRANSCRIPTION; GENETICS; HELA CELL; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; HUMAN; ISOLATION AND PURIFICATION; METHODOLOGY;

ANTINEOPLASTIC AGENTS; BOSWELLIA; CHROMATOGRAPHY, HIGH PRESSURE LIQUID; DRUG SCREENING ASSAYS, ANTITUMOR; HELA CELLS; HUMANS; HYPOXIA-INDUCIBLE FACTOR 1, ALPHA SUBUNIT; MOLECULAR IMPRINTING; POLYMERS; QUERCETIN; SOLID PHASE EXTRACTION; TRANSCRIPTION, GENETIC; TRITERPENES;

EID: 84856067546     PISSN: 01676997     EISSN: 15730646     Source Type: Journal    
DOI: 10.1007/s10637-010-9440-4     Document Type: Article

References (43)

1. Semenza GL (2000) HIF-1 and human disease: one highly involved factor. Genes Dev 14(16):1983-1991
2. Park JW, Chun YS, Kim MS (2004) Hypoxia-inducible factor 1-related diseases and prospective therapeutic tools. J Pharmacol Sci 94(3):221-232
3. Wenger RH (2002) Cellular adaptation to hypoxia: O2-sensing protein hydroxylases, hypoxia-inducible transcription factors, and O2-regulated gene expression. FASEB J 16(10):1151-1162
4. Semenza GL (2007) Evaluation of HIF-1 inhibitors as anticancer agents. Drug Discov Today 12(19-20):853-859
5. Giaccia A, Siim BG, Johnson RS (2003) HIF-1 as a target for drug development. Nat Rev Drug Discov 2(10):803-811
6. Semenza GL (2003) Targeting HIF-1 for cancer therapy. Nat Rev Cancer 3(10):721-732
7. Belozerov VE, Van Meir EG (2005) Hypoxia inducible factor-1: a novel target for cancer therapy. Anticancer Drugs 16(9):901-909
8. Semenza GL (2008) Hypoxia-inducible factor 1 and cancer pathogenesis. IUBMB Life 60(9):591-597
9. Nagle DG, Zhou YD (2006) Natural product-based inhibitors of hypoxia-inducible factor-1(HIF-1). Curr Drug Targets 7 (3):355-369
10. Triantafyllou A, Mylonis I, Simos G et al (2008) Flavonoids induce HIF-1alpha but impair its nuclear accumulation and activity. Free Radic Biol Med 44(4):657-670
11. Kong D, Park EJ, Stephen AG et al (2005) Echinomycin, a smallmolecule inhibitor of hypoxia-inducible factor-1 DNA-binding activity. Cancer Res 65(19):9047-9055
12. Olenyuk BZ, Zhang GJ, Klco JM et al (2004) Inhibition of vascular endothelial growth factor with a sequence-specific hypoxia response element antagonist. Proc Natl Acad Sci U S A 101(48):16768-16773
13. Kung AL, Zabludoff SD, France DS et al (2004) Small molecule blockade of transcriptional coactivation of the hypoxia-inducible factor pathway. Cancer Cell 6(1):33-43
14. Melillo G (2006) Inhibiting hypoxia-inducible factor 1 for cancer therapy. Mol Cancer Res 4(9):601-605
15. Mabjeesh NJ, Post DE, Willard MT et al (2002) Geldanamycin induces degradation of hypoxia-inducible factor 1alpha protein via the proteosome pathway in prostate cancer cells. Cancer Res 62(9):2478-2482
16. Semenza GL (2007) Hypoxia-inducible factor 1 (HIF-1) pathway. Science's STKE 2007 (407): cm8
17. Brian S, Blagg J, Kerr TD (2006) Hsp90 inhibitors: Small molecules that transform the Hsp90 protein folding machinery into a catalyst for protein degradation. Med Res Rev 26(3):310-338
18. Aggarwal BB, Sethi G, Baladandayuthapani V et al (2007) Targeting cell signaling pathways for drug discovery: an old lock needs a new key. J Cell Biochem 102(3):580-592
19. Rapisarda A, Uranchimeg B, Scudiero DA et al (2002) Identification of small molecule inhibitors of hypoxia-inducible factor 1 transcriptional activation pathway. Cancer Res 62(15):4316-4324
20. Dai J, Liu Y, Jia H et al (2007) Benzochromenones from the marine crinoid Comantheria rotula inhibit Hypoxia-Inducible Factor-1(HIF-1) in cell-based reporter assays and differentially suppress the growth of certain tumor cell lines. J Nat Prod 70 (9):1462-1466
21. Dai J, Fishback JA, Zhou YD et al (2006) Sodwanone and yardenone triterpenes from a South African species of the marine sponge Axinella inhibit hypoxia-inducible factor-1(HIF-1) activation in both breast and prostate tumor cells. J Nat Prod 69 (12):1715-1720
22. Mohammed KA, Hossain CF, Zhang L et al (2004) Laurenditerpenol, a new diterpene from the tropical marine alga Laurencia intricata that potently inhibits HIF-1 mediated hypoxic signaling in breast tumor cells. J Nat Prod 67(12):2002-2007
23. Koehn FE, Carter GT (2005) The evolving role of natural products in drug discovery. Nat Rev Drug Discov 4(3):206-220
24. Ortholand J-Y, Ganesan A (2004) Natural products and combinatorial chemistry: back to the future. Curr Opin Chem Biol 8(3):271-280
25. Koehn FE (2008) High impact technologies for natural products screening. Prog Drug Res 65:176-210
26. Rathbone DL (2005) Molecularly imprinted polymers in the drug discovery process. Adv Drug Deliv Rev 57(12):1854-1874
27. van Nostrum CF (2005) Molecular imprinting: A new tool for drug innovation. Drug Discov Today: Technol 2(1):119-124
28. Sellergren B (2003) Molecularly imprinted polymers: man-made mimics of antibodies and their applications in analytical chemistry. Elsevier, Amsterdam
29. Karpozilos A, Pavlidis N (2004) The treatment of cancer in Greek antiquity. Eur J Cancer 40(14):2033-2040
30. Takada Y, Ichikawa H, Badmaev V et al (2006) Acetyl-11-keto-β- boswellic acid potentiates apoptosis, inhibits invasion, and abolishes osteoclastogenesis by suppressing NF-κB and NF-κB-regulated gene expression. J Immunol 176(5):3127-3140
31. O'Mahony J, Molinelli A, Nolan K et al (2006) Anatomy of a successful imprint: analysing the recognition mechanisms of a molecularly imprinted polymer for quercetin. Biosens Bioelectron 21(7):1383-1392
32. Umpleby RJ 2nd, Baxter SC, Rampey AM et al (2004) Characterization of the heterogeneous binding site affinity distributions in molecularly imprinted polymers. J Chromatogr B Anal Technol Biomed Life Sci 804(1):141-149
33. Lyberopoulou A, Venieris E, Mylonis I et al (2007) MgcRacGAP interacts with HIF-1alpha and regulates its transcriptional activity. Cell Physiol Biochem 20(6):995-1006
34. Mylonis I, Chachami G, Samiotaki M et al (2006) Identification of MAPK phosphorylation sites and their role in the localization and activity of hypoxia-inducible factor-1alpha. J Biol Chem 281(44):33095-33106
35. Kim H, Spivak DA (2003) New insight into modeling non-covalently imprinted polymers. J Am Chem Soc 125(37):11269-11275
36. Buchele B, Simmet T (2003) Analysis of 12 different pentacyclic triterpenic acids from frankincense in human plasma by highperformance liquid chromatography and photodiode array detection. J Chromatogr B Anal Technol Biomed Life Sci 795(2):355-362
37. Banno N, Akihisa T, Yasukawa K et al (2006) Anti-inflammatory activities of the triterpene acids from the resin of Boswellia carteri. J Ethnopharmacol 107(2):249-253
38. Manolescu B, Oprea E, Busu C et al (2009) Natural compounds and the hypoxia-inducible factor (HIF) signalling pathway. Biochimie 91(11-12):1347-1358
39. Triantafyllou A, Liakos P, Tsakalof A et al (2007) The flavonoid quercetin induces hypoxia-inducible factor-1alpha (HIF-1alpha) and inhibits cell proliferation by depleting intracellular iron. Free Radic Res 41(3):342-356
40. Lee DH, Lee YJ (2008) Quercetin suppresses hypoxia-induced accumulation of hypoxia-inducible factor-1alpha (HIF-1alpha) through inhibiting protein synthesis. J Cell Biochem 105(2):546-553
41. Eckert H, Bajorath J (2007) Molecular similarity analysis in virtual screening: foundations, limitations and novel approaches. Drug Discov Today 12(5-6):225-233
42. Baringhaus K-H, Hessler G (2004) Fast similarity searching and screening hit analysis. Drug Discov Today: Technol 1(3):197-202
43. Plewczynski D, Spieser SA, Koch U (2009) Performance of machine learning methods for ligand-based virtual screening. Comb Chem High Throughput Screen 12(4):358-368